Drugs / FluMist Quadrivalent (2017-2018)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03143101 | May → Sep 2017 | influenza | MedImmune LLC | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FluMist Quadrivalent (2017-2018) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03143101 ↗ |
| Modality | Vaccine | “FluMist quadrivalent vaccine” NCT03143101 ↗ |
| Route | Intranasal | “receive intranasal spray” NCT03143101 ↗ |